Precision cancer drugs called PARP inhibitors have a previously unknown ability to boost the immune system, and could help many more patients benefit from immunotherapy, a new study reveals.
from Breast Cancer News -- ScienceDaily https://ift.tt/2IY3vGW
0 comments:
Post a Comment